Mycobacterium leprae was identified in 1873 as the cause of leprosy by Gerhard Armauer Hansen, a Norwegian physician and pathologist. His work fundamentally altered the medical understanding of the disease, shifting the consensus from theories of heredity and miasma to the recognition of a communicable bacterial agent identified through systematic epidemiological observation and microscopic examination.
Early Career and Education
Born in Bergen in 1841, Hansen attended the Bergen Cathedral School before pursuing his studies at the University of Oslo. His professional trajectory initially involved clinical practice at the Rikshospitalet in Christiania and as a medical officer in Lofoten. In 1868, he returned to his home city to accept a position at Lungegård Hospital. There, he worked alongside Daniel Cornelius Danielssen, an expert in leprosy, initiating the research that would define his career.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Bacterial Identification
Seeking to prove his hypothesis that leprosy was communicable, Hansen traveled to Bonn and Vienna between 1870 and 1873 to acquire advanced research skills. Upon his return, he employed superior microscopic equipment to examine patient tissues. He announced the discovery of Mycobacterium leprae in 1873. While his initial findings faced skepticism due to his inability to culture the organism, his observations eventually provided the empirical foundation for modern leprosy control.
Controversy and Research Integrity
His reputation suffered following a dispute with Albert Neisser, who claimed credit for the discovery after Hansen provided him with samples in 1879. Furthermore, Hansen faced significant legal challenges after attempting to infect a patient with the nodular form of leprosy without consent. Although he was removed from his hospital post, this incident was instrumental in the development of informed consent regulations for medical research in Norway.
Public Policy and Institutional Legacy
Hansen leveraged his findings to influence public health policy, spearheading the leprosy acts of 1877 and 1885. These legislative measures contributed to a marked decline in cases within Norway, dropping from 1,800 in 1875 to 575 by 1901. Beyond his medical contributions, he served as a board member for the Bergen chapter of the Norwegian Association for Women's Rights. He died in Florø in 1912.
Fast facts
- Born: 1841, Bergen, Norway
- Died: 1912, Florø, Norway
- Primary medical field: Leprosy
- Education: University of Oslo; Bergen Cathedral School
- Award: Knight First Class of the Order of St. Olav (1892)
- Professional memberships: Norwegian Academy of Science and Letters
- Key discovery year: 1873
Questions readers ask
Did Hansen identify Mycobacterium leprae as bacteria in 1873?
While he identified the presence of the organism in patient tissues in 1873, he did not initially classify it as bacteria.
What was the significance of the 1877 and 1885 leprosy acts?
These acts were national policies in Norway that enabled a significant reduction in the prevalence of leprosy, decreasing known cases by over 60 percent within three decades.
Achievements
- Educated at Bergen Cathedral School and University of Oslo
- Fields of research: leprosy
